Russia transfers technology to produce new generation drugs and vaccines to Vietnam

On September 12, VNVC Vaccine and Biological Factory and Medsintez Pharmaceutical Company (Russian Federation) signed a cooperation agreement on technology transfer for comprehensive production of new generation biological drugs for the treatment of many dangerous acute and chronic diseases. The signing ceremony took place under the witness of Russian Minister of Health Mikhail Murashko and Vietnamese Minister of Health Dao Hong Lan.

Mr. Konstantin Gorodnitsky, Head of Medsintez Company Representative Office in Vietnam, and Ms. Tran Thi Hong Thuy, Director of VNVC Vaccine and Biological Factory, signed the cooperation agreement under the witness of Russian Minister of Health Mikhail Murashko and Vietnamese Minister of Health Dao Hong Lan. Photo: Pham Giang

Previously, in May 2025 in Moscow, under the witness of Russian President Putin and General Secretary To Lam , the two ministers signed a cooperation agreement and witnessed VNVC signing a comprehensive cooperation agreement with the Russian Direct Investment Fund (RDIF) - the highest representative of Russian pharmaceutical research and production agencies as well as other health agencies.

After 5 months, VNVC has reached a comprehensive technology transfer agreement with Medsintez - a large Russian pharmaceutical company, to soon bring to Vietnam to produce the world's leading advanced biological drugs from Russia for the treatment of diabetes, obesity, vascular diseases, viral diseases, especially dengue fever.

The signing of this cooperation agreement is an important step in concretizing the policy of extensive cooperation in health between the two countries, and at the same time realizing the policy of Resolution 57 and Resolution 72 of the Politburo on breakthroughs in science and technology development, innovation, strengthening protection, care and improvement of people's health as well as the National Strategy for the development of Vietnam's pharmaceutical industry to 2030 and vision to 2045 of the Government.

VNVC Vaccine Company and the Russian Direct Investment Fund (RDIF) exchanged cooperation documents in the presence of Russian President Putin and General Secretary To Lam. Photo: Hoang Thong Nhat

Immediately after signing, Medsintez and VNVC will carry out steps to transfer Medsintez's advanced biological drug production technology at VNVC Vaccine and Biological Factory, cooperate in research and development and clinical research of new drugs and vaccines, and distribute Medsintez's high-quality pharmaceutical products in Vietnam and ASEAN countries.

It is expected that in the near future, many advanced biological drug categories of Medsintez will be transferred for production at VNVC Vaccine and Biological Factory with high international standards, such as Recombinant Albumin, Recombinant Insulin, disposable and reusable Insulin pens, diabetes treatment drugs (liraglutide, semaglutide), anticoagulant Heparin (prevention and treatment of thrombotic complications causing blood vessel blockage leading to stroke, myocardial infarction, pulmonary embolism), antiviral drug Triazavirin, follicle stimulating hormone (used in infertility treatment)...

In particular, the two sides will discuss the coordination of clinical research on the antiviral drug Triazavirin in the treatment of dengue fever, a disease that causes hundreds of thousands of cases and dozens of deaths each year in Vietnam.

Speaking at the event, Russian Minister of Health Mikhail Murashko said: “I believe that the cooperation between Vietnam and Russia will bring mutual benefits, aiming at the highest goal of protecting people's health and improving the quality of the healthcare sector.”

Ms. Dao Hong Lan, Minister of Health of Vietnam, expressed her joy at witnessing the cooperation between research institutes, high-tech medical centers and prestigious units in the medical field of the two countries, which will open up many practical cooperation programs, especially in cancer treatment with advanced technology as well as the production of drugs, vaccines and medical biological products - which are urgent needs not only of Vietnam, Russia but also of the world.

Mr. Ngo Chi Dung, Chairman of the Board of Directors and General Director of VNVC Vaccine and Biological Factory shared: “Together with Government agencies and medical units, the Tam Anh - VNVC medical ecosystem is striving to realize the contents of Resolutions 57, 28, 68, 72 of the Politburo on breakthroughs in public health care, enhancing self-reliance in the production of high-tech pharmaceuticals and vaccines, contributing to ensuring national health security.

It is expected that by the end of 2027, the VNVC Vaccine and Biological Factory will begin producing new generation vaccines and advanced biological drugs from many countries around the world right in Vietnam.

The groundbreaking ceremony of the VNVC Vaccine and Biological Factory was witnessed and pressed the button by French President Emmanuel Macron during his visit and working visit to Vietnam. Photo: Hai Nam

The event of VNVC signing with Medsintez is not only an important step forward for VNVC in the process of international cooperation and integration, but also affirms the capacity of Vietnamese enterprises to receive and master the world's leading advanced technologies.

This cooperation also opens up opportunities for Vietnam to access early sources of high-quality biological drugs in the treatment of infectious diseases and dangerous chronic diseases, gradually shortening the roadmap for mastering technology, reducing import costs, moving towards self-sufficiency in domestic supply and moving towards export, thereby affirming its position as a prestigious center for the production and supply of vaccines and biological products in the ASEAN region.

Source: https://baolangson.vn/nga-chuyen-giao-cong-nghe-san-xuat-thuoc-va-vac-xin-the-he-moi-cho-viet-nam-5058850.html